Insight Molecular Diagnostics
Business Services · Tennessee, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
2 International Plz Ste 510, Nashville, ...Phone Number
(615) 255-8880Website
www.imdxinc.comRevenue
$5.9 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Insight Molecular Diagnostics
iMDx specializes in precision diagnostics for oncology and transplantation, providing innovative solutions that cater to the needs of researchers, clinicians, and healthcare systems. Their product offerings include molecular diagnostic tools designed for early detection, treatment guidance, and research applications. The company is committed to advancing precision medicine and improving patient outcomes through actionable insights and scalable diagnostic solutions. iMDx aims to democratize access to molecular diagnostic testing, creating sustainable value for healthcare providers and patients alike.Explore more
Insight Molecular Diagnostics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Insight Molecular Diagnostics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Insight Molecular Diagnostics, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Insight Molecular Diagnostics recently announced quarterly report
Check out if Insight Molecular Diagnostics is spiking on competitors!
Product Launch: Get notified when Insight Molecular Diagnostics launches new products
Website visits: Recent activity has been detected on your website
Check if Insight Molecular Diagnostics has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Insight Molecular Diagnostics had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Insight Molecular Diagnostics
Funding: Get notified immidiatlly once Insight Molecular Diagnostics has new funding data
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Company Profile Activity
Activity Insights
Insight Molecular Diagnostics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Insight Molecular Diagnostics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Insight Molecular Diagnostics.
Insight Molecular Diagnostics Tech Stack
A closer look at the technologies used by Insight Molecular Diagnostics
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
Open Position
Earnings
continues to target an average cash burn of about $6 million per quarter until its commercial launch next year, with expectations of higher burn in Q3 before coming back down in Q4. The company noted that the biggest factors affecting cash management are its clinical trial and the purchase of discounted instruments to support the trial at partner sites.
Earnings, Financial Planning, Business Finance, Finance, Financial Strategy
Earnings
reported sales of $24,000 worth of first-generation Raft Assured IQ kits in Q2. The company began shipping second-generation kits to customers in June, with initial kits provided as free samples for lab validation.
Earnings, Product Launch, Finance, Healthcare Technology
Earnings
Earnings, Accounting, Financial Reporting, Business Finance, Finance
Insight Molecular Diagnostics News & Media
iMDx and the American Society of Transplant Surgeons Announce Recipients of the ASTS-iMDx Health Economics Research Grant
-Grant Supports Health Economic Research Comparing In-House versus Send-Out dd-cfDNA Testing in Kidney Transplantation-Favorable Head-to-Head Data on iMDx’s GraftAssure with Competing NGS Assay Published in Clinical Chemistry
NASHVILLE, Tenn., June 16, 2026 (GLOBE NEWSWIRE) -- Insight Molecular Diagnostics Inc., (Nasdaq: IMDX) ("iMDx") today announced the online publication of a favorable article in Clinical Chemistry, the premier, peer-reviewed scientific publication of the Association for Diagnostics & Laboratory Medicine. The article highlights the concordant performance between iMDx's digital-PCR-based flagship transplant monitoring test, GraftAssure™, and a competing next-generation-sequencing-based assay kit thIMDX GraftAssure Assay Sets New Standard in Screening Kidney Transplant Patients Per American Journal of Transplantation
NASHVILLE, Tenn., June 11, 2026 (GLOBE NEWSWIRE) -- Insight Molecular Diagnostics Inc., (Nasdaq: IMDX), (iMDx), today announced an online published article in the American Journal of Transplantation asserting statistical superiority of the company’s flagship GraftAssure transplant rejection monitoring assay.iMDx to Highlight In-House Transplant Testing Opportunity and Host Key Opinion Leaders at American Transplant Congress
NASHVILLE, Tenn., June 09, 2026 (GLOBE NEWSWIRE) -- Insight Molecular Diagnostics Inc., (Nasdaq: IMDX), (iMDx), today announced it will be highlighting its GraftAssure™ technology at the upcoming American Transplant Congress, to be held in Boston from Saturday, June 20th through Wednesday, June 24th.
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Insight Molecular Diagnostics
Sign Up For FreeTo access detailed company insights
iMDx specializes in precision diagnostics for oncology and transplantation, providing innovative solutions that cater to the needs of researchers, clinicians, and healthcare systems. Their product offerings include molecular diagnostic tools designed for early detection, treatment guidance, and research applications. The company is committed to adv... Read More
